Exome sequencing for prenatal diagnosis in nonimmune hydrops fetalis

T. N. Sparks, B. R. Lianoglou, R. R. Adami, I. D. Pluym, K. Holliman, J. Duffy, S. L. Downum, S. Patel, A. Faubel, Nina Boe, N. T. Field, A. Murphy, L. C. Laurent, J. Jolley, C. Uy, A. M. Slavotinek, P. Devine, U. Hodoglugil, J. van Ziffle, S. J. SandersT. C. MacKenzie, M. E. Norton

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

BACKGROUND The cause of most fetal anomalies is not determined prenatally. Exome sequencing has transformed genetic diagnosis after birth, but its usefulness for prenatal diagnosis is still emerging. Nonimmune hydrops fetalis (NIHF), a fetal abnormality that is often lethal, has numerous genetic causes; the extent to which exome sequencing can aid in its diagnosis is unclear. METHODS We evaluated a series of 127 consecutive unexplained cases of NIHF that were defined by the presence of fetal ascites, pleural or pericardial effusions, skin edema, cystic hygroma, increased nuchal translucency, or a combination of these conditions. The primary outcome was the diagnostic yield of exome sequencing for detecting genetic variants that were classified as either pathogenic or likely pathogenic according to the criteria of the American College of Medical Genetics and Genomics. Secondary outcomes were the percentage of cases associated with specific genetic disorders and the proportion of variants that were inherited. RESULTS In 37 of the 127 cases (29%), we identified diagnostic genetic variants, including those for disorders affecting the RAS–MAPK cell-signaling pathway (known as RASopathies) (30% of the genetic diagnoses); inborn errors of metabolism and musculoskeletal disorders (11% each); lymphatic, neurodevelopmental, cardiovascular, and hematologic disorders (8% each); and others. Prognoses ranged from a relatively mild outcome to death during the perinatal period. Overall, 68% of the cases (25 of 37) with diagnostic variants were autosomal dominant (of which 12% were inherited and 88% were de novo), 27% (10 of 37) were autosomal recessive (of which 95% were inherited and 5% were de novo), 1 was inherited X-linked recessive, and 1 was of uncertain inheritance. We identified potentially diagnostic variants in an additional 12 cases. CONCLUSIONS In this large case series of 127 fetuses with unexplained NIHF, we identified a diagnostic genetic variant in approximately one third of the cases. (Funded by the UCSF Center for Maternal–Fetal Precision Medicine and others; ClinicalTrials.gov number, NCT03412760.)

Original languageEnglish (US)
Pages (from-to)1746-1756
Number of pages11
JournalNew England Journal of Medicine
Volume383
Issue number18
DOIs
StatePublished - Oct 29 2020

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Exome sequencing for prenatal diagnosis in nonimmune hydrops fetalis'. Together they form a unique fingerprint.

Cite this